ArticleBMJ paediatrics open2026
Neonatal encephalopathy mortality rate in Aotearoa, New Zealand: review of national data 2010-2020.
Article in BMJ paediatrics open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeonatal encephalopathy (NE) is a condition that affects newborn and can lead to long-term neurological impairments and death. Hypoxic ischaemic encephalopathy is the subset of NE with evidence of a hypoxic ischaemic insult. In Aotearoa New Zealand, national data have been collected for infants ≥37 weeks since 2010 and ≥35 weeks from 2016. Although the mortality rate associated with NE has not been a focus of annual reports, it is an important outcome for counselling whānau (families) and for international comparison.
methodsThe Perinatal and Maternal Mortality Review Committee (PMMRC) dataset was used to calculate mortality rate for cases of moderate/severe NE for two gestational groups, 35 weeks to 36 weeks+6 days (2016-20) and ≥37 weeks (2010-2020). Annual mortality rates in infants ≥37 weeks with NE for the period 2010-20 were calculated overall and by prioritised ethnic group.
resultsIn the PMMRC dataset, there was frequently a history of fetal distress or antenatal sentinel event with the vast majority of included infants having low Apgar scores and requiring resuscitation at birth. The mortality rate was 0.23/1000 births (95% CL 0.17-0.29) for infants ≥37 weeks with no significant change over the study period. The mortality rate for infants with NE between 35 and 36+6 weeks was 0.68/1000 births (95% CL 0.31-1.28), giving a relative risk of 2.99 in preterm compared with term infants with NE. No statistical difference in mortality by prioritised ethnic group was demonstrated.
conclusionsThere has been no improvement in mortality rates for infants with NE despite ongoing efforts to improve early recognition and treatment. Preterm infants were at significantly higher risk of death. The analysis did not demonstrate any ethnic differences in mortality associated with NE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.